Good presentation and negotiation skills with the ability to timely resolve conflict in a constructive manner. Good communication skills with a proven ability to effectively engage and manage key internal stakeholders in various functions and geographies. Experience in matrix management is desirable with the ability to engage, inspire and influence others.Strategic influence via translation of data insights into impactful storytelling.Statistical acumen is required, with experience of making decisions based on statistical forecasting.
JOBS FOR BUSINESS MAJORS FOR PRINCETON NJ TRIAL
Robust understanding of the drug development process and global clinical operations with an exceptional understanding of clinical trial feasibility is required.At least 8 years clinical trial operations experience is required. A degree in Quantitative Science or equivalent is preferred. A minimum of a Bachelor's Degree is required.Developing and promoting a work place culture that values diversity of thought, promotes integrity and creates an atmosphere that supports coaching and fosters accountability.Developing productive working relationships with key stakeholders throughout BMS with the ability to think strategically and effectively express his/her views.Representing Clinical Trial Business Planning as needed in matrix forums, strategic teams or committees (preparatory materials, direct participation, or representative).Partnering across Clinical Trial Business Operations and stakeholders to proactively identify risks and issues, action and prioritize associated mitigations and process improvements.Representing and collaborating with Global Development Operation functions to translate demands of upcoming work into functional support strategies.Driving decision support for internal trade-off and prioritization activities.
Ensuring regional resources are applied to where they have the most impact, with consideration to long term development and portfolio nuances.Driving portfolio optimization, that maximizes enrollment and recruitment potential across studies and programs, through collaboration with key business partners that is aligned with Regulatory, Medical and Commercial asset strategy and operational capability development.Requires engagement across a diverse stakeholder engagement model, as well as identification and resolution of incentive conflicts. Specific implications around competing trials and synergistic opportunities are pertinent. Identifying and incorporating implications to the delivery of the entire Book of Work, when driving decisions at study level.Strengthening data-driven decision making, through partnership with a central analytics organization (Business Insights & Analytics) and internal stakeholders, to synthesize, interpret, and integrate data and information into allocation strategy development.Improving executional outcomes across the portfolio (ex shorter recruitment timelines, lower site costs and waste), leading to accelerated pace of outcomes while balancing costs and quality via challenging operational status quo and pushing for innovative and rationale implementation strategies.
We bring a human touch to every treatment we pioneer. In oncology, hematology, immunology and cardiovascular disease – and one of the most diverse and promising pipelines in the industry – each of our passionate colleagues contribute to innovations that drive meaningful change. At Bristol Myers Squibb, we are inspired by a single vision – transforming patients’ lives through science.
0 kommentar(er)
